ALTAMURA, CONCETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.329
EU - Europa 502
AS - Asia 204
SA - Sud America 18
Totale 2.053
Nazione #
US - Stati Uniti d'America 1.325
DE - Germania 116
IT - Italia 113
SE - Svezia 103
CN - Cina 94
SG - Singapore 81
RU - Federazione Russa 72
GB - Regno Unito 41
BR - Brasile 17
FI - Finlandia 17
FR - Francia 15
VN - Vietnam 11
BE - Belgio 7
IN - India 6
NL - Olanda 6
UA - Ucraina 5
CA - Canada 3
TR - Turchia 3
IE - Irlanda 2
JP - Giappone 2
UZ - Uzbekistan 2
AR - Argentina 1
AT - Austria 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
NP - Nepal 1
PH - Filippine 1
PL - Polonia 1
TW - Taiwan 1
Totale 2.053
Città #
Fairfield 217
Ashburn 141
Chandler 133
Houston 111
Woodbridge 107
Nyköping 86
Cambridge 73
Singapore 60
Wilmington 60
Ann Arbor 58
Seattle 58
Bari 48
Beijing 23
Roxbury 23
Lawrence 21
Inglewood 20
New York 20
Des Moines 17
Jacksonville 17
San Diego 15
Nanjing 14
Santa Clara 12
Dong Ket 10
Helsinki 9
London 9
Paris 9
Los Angeles 8
Washington 8
Princeton 7
Montignoso 6
Pune 6
Brooklyn 5
Brussels 5
Milan 5
Wuhan 5
Changsha 4
Dearborn 4
Guangzhou 4
Mottola 4
Nanchang 4
Grottaglie 3
Shanghai 3
Shenyang 3
Toronto 3
Boardman 2
Chicago 2
Chongqing 2
Dublin 2
Esslingen am Neckar 2
Florence 2
Hebei 2
Hohenstein-Ernstthal 2
Jiaxing 2
Magliano Alpi 2
Münster 2
Naples 2
Norwalk 2
Nuremberg 2
Perugia 2
Redwood City 2
Rome 2
San Mateo 2
Taranto 2
Tashkent 2
Tianjin 2
Tokyo 2
Triggiano 2
Vinovo 2
Waanrode 2
Wenzhou 2
Acquaviva delle Fonti 1
Andria 1
Asnières-sur-Seine 1
Augusta 1
Brasília 1
Brno 1
Cajamar 1
Camalaú 1
Carmo do Rio Verde 1
Castelnuovo Rangone 1
Caxias do Sul 1
Cerquilho 1
Clifton 1
Denver 1
Dores do Turvo 1
Extrema 1
Fasano 1
Fort Worth 1
Frankfurt am Main 1
Giresun 1
Gravina In Puglia 1
Ho Chi Minh City 1
Ibirubá 1
Ipubi 1
Jaboatão dos Guararapes 1
Jaraguá 1
Jinan 1
Krasnoyarsk 1
Kunming 1
Leawood 1
Totale 1.540
Nome #
Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies 162
ClC-1 chloride channels: state-of-the-art research and future challenges 154
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate 141
Mapping ligand binding pockets in ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid 137
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 132
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within CBS2 domain and C-terminal peptide of ClC-1 channel 114
ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation 112
Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia 110
Effects of Benzothiazolamines on Voltage-Gated Sodium Channels 100
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 99
Ion channels gene expression analysis in myotonia congenita patients carrying ClC-1 chloride channel mutations 70
Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo 68
Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes. 64
Skeletal muscle ClC-1 chloride channels in health and diseases 62
Synthesis and Evaluation of Voltage-Gated Sodium Channel Blocking Pyrroline Derivatives Endowed with Both Antiarrhythmic and Antioxidant Activities 62
Pathomechanisms of a CLCN1 Mutation Found in a Russian Family Suffering From Becker's Myotonia 53
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 53
Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel 46
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders 43
Natural ClC-1 mutations causing myotonia congenita reduce sensitivity to 9-AC 41
Emerging roles for ion channels in ovarian cancer: Pathomechanisms and pharmacological treatment 39
Buprenorphine may be effective for treatment of paramyotonia congenita 39
Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine 38
Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome 35
Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy 30
null 29
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 28
Ion Channel Involvement in Tumor Drug Resistance 24
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review 18
Anti-Angiogenic Activity of Drugs in Multiple Myeloma 18
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 16
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 15
Drug repurposing in skeletal muscle ion channelopathies 14
ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells 13
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 13
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 12
A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia 11
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 10
Target mutation-driven drug discovery 10
Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management 8
Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model 5
Totale 2.248
Categoria #
all - tutte 11.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020182 0 0 0 0 0 22 23 27 31 34 35 10
2020/2021440 34 26 32 48 32 42 47 21 31 64 32 31
2021/2022239 17 15 5 20 4 14 4 11 16 40 42 51
2022/2023356 35 54 33 17 24 52 11 54 46 9 14 7
2023/2024197 8 30 15 21 25 61 3 4 5 8 8 9
2024/2025300 42 4 43 40 97 74 0 0 0 0 0 0
Totale 2.248